103 related articles for article (PubMed ID: 2096922)
21. Targeting of macromolecular carriers and liposomes by antibodies to myosin heavy chain.
Klibanov AL; Khaw BA; Nossiff N; O'Donnell SM; Huang L; Slinkin MA; Torchilin VP
Am J Physiol; 1991 Oct; 261(4 Suppl):60-5. PubMed ID: 1928455
[TBL] [Abstract][Full Text] [Related]
22. Development of a bifunctional crosslinking agent with potential for the preparation of immunotoxins.
McKenzie JA; Raison RL; Rivett DE
J Protein Chem; 1988 Oct; 7(5):581-92. PubMed ID: 3267139
[TBL] [Abstract][Full Text] [Related]
23. The effect of chelating agents on the distribution of monoclonal antibodies in mice.
Ward MC; Roberts KR; Westwood JH; Coombes RC; McCready VR
J Nucl Med; 1986 Nov; 27(11):1746-50. PubMed ID: 3464701
[TBL] [Abstract][Full Text] [Related]
24. Monoclonal antibody modification with chelate-linked high-molecular-weight polymers: major increases in polyvalent cation binding without loss of antigen binding.
Torchilin VP; Klibanov AL; Nossiff ND; Slinkin MA; Strauss HW; Haber E; Smirnov VN; Khaw BA
Hybridoma; 1987 Jun; 6(3):229-40. PubMed ID: 3110049
[TBL] [Abstract][Full Text] [Related]
25. A comparison of cleavable and noncleavable hydrazinopyridine linkers for the 99mTc labeling of Fab' monoclonal antibody fragments.
Bridger GJ; Abrams MJ; Padmanabhan S; Gaul F; Larsen S; Henson GW; Schwartz DA; Longley CB; Burton CA; Ultee ME
Bioconjug Chem; 1996; 7(2):255-64. PubMed ID: 8983348
[TBL] [Abstract][Full Text] [Related]
26. Monoclonal antibody 44-3A6 doxorubicin immunoconjugates: comparative in vitro anti-tumor efficacy of different conjugation methods.
Sinkule JA; Rosen ST; Radosevich JA
Tumour Biol; 1991; 12(4):198-206. PubMed ID: 1651554
[TBL] [Abstract][Full Text] [Related]
27. Effect of the extent of chelate substitution on the immunoreactivity and biodistribution of 2IT-BAT-Lym-1 immunoconjugates.
Kukis DL; DeNardo GL; DeNardo SJ; Mirick GR; Miers LA; Greiner DP; Meares CF
Cancer Res; 1995 Feb; 55(4):878-84. PubMed ID: 7850803
[TBL] [Abstract][Full Text] [Related]
28. Synthesis of N-[tris[2-[[N-(benzyloxy)amino]carbonyl]ethyl]methyl]succinamic acid, trisuccin. Hydroxamic acid derivatives as a new class of bifunctional chelating agents.
Safavy A; Buchsbaum DJ; Khazaeli MB
Bioconjug Chem; 1993; 4(3):194-8. PubMed ID: 8324008
[TBL] [Abstract][Full Text] [Related]
29. A carbohydrate-directed heterobifunctional cross-linking reagent for the synthesis of immunoconjugates.
Zara JJ; Wood RD; Boon P; Kim CH; Pomato N; Bredehorst R; Vogel CW
Anal Biochem; 1991 Apr; 194(1):156-62. PubMed ID: 1867379
[TBL] [Abstract][Full Text] [Related]
30. Stability and cytotoxicity of Fab-ricin A immunotoxins prepared with water soluble long chain heterobifunctional crosslinking agents.
Woo BH; Lee JT; Park MO; Lee KR; Han JW; Park ES; Yoo SD; Lee KC
Arch Pharm Res; 1999 Oct; 22(5):459-63. PubMed ID: 10549572
[TBL] [Abstract][Full Text] [Related]
31. Nature of the bifunctional chelating agent used for radioimmunotherapy with yttrium-90 monoclonal antibodies: critical factors in determining in vivo survival and organ toxicity.
Kozak RW; Raubitschek A; Mirzadeh S; Brechbiel MW; Junghans RP; Gansow OA; Waldmann TA
Cancer Res; 1989 May; 49(10):2639-44. PubMed ID: 2785435
[TBL] [Abstract][Full Text] [Related]
32. Negatively charged polymers protect antinuclear antibody against inactivation by acylating agents.
Samokhin GP; Mongayt DA; Iakoubov LZ; Levchenko TS; Torchilin VP
Anal Biochem; 2001 May; 292(2):245-9. PubMed ID: 11355857
[TBL] [Abstract][Full Text] [Related]
33. Ricin A immunotoxins of IgG and Fab of anti-CALLA monoclonal antibody: effect of water soluble long-chain SPDP on conjugate yield, immunoselectivity and cytotoxicity.
Woo BH; Lee JT; Lee KC
Arch Pharm Res; 1994 Dec; 17(6):452-7. PubMed ID: 10319157
[TBL] [Abstract][Full Text] [Related]
34. Synthesis, pharmacokinetics, and biodistribution of 67GA deferoxamineacetyl-cysteinylbiotin.
Hashmi M; Rosebrough SF
Drug Metab Dispos; 1995 Dec; 23(12):1362-7. PubMed ID: 8689944
[TBL] [Abstract][Full Text] [Related]
35. High-level conjugation of chelating agents onto immunoglobulins: use of an intermediary poly(L-lysine)-diethylenetriaminepentaacetic acid carrier.
Manabe Y; Longley C; Furmanski P
Biochim Biophys Acta; 1986 Oct; 883(3):460-7. PubMed ID: 3756213
[TBL] [Abstract][Full Text] [Related]
36. Basic evaluation of 67Ga labeled digoxin derivative as a metal-labeled bifunctional radiopharmaceutical.
Fujibayashi Y; Takemura Y; Taniuchi H; Iijima N; Konishi J; Yokoyama A
Ann Nucl Med; 1993 Nov; 7(4):239-44. PubMed ID: 8292449
[TBL] [Abstract][Full Text] [Related]
37. Simplified method for conjugating macrocyclic bifunctional chelating agents to antibodies via 2-iminothiolane.
McCall MJ; Diril H; Meares CF
Bioconjug Chem; 1990; 1(3):222-6. PubMed ID: 2096914
[TBL] [Abstract][Full Text] [Related]
38. Construction and chemotherapeutic potential of carboxypeptidase-A/monoclonal antibody conjugate.
Esswein A; Hänseler E; Montejano Y; Vitols KS; Huennekens FM
Adv Enzyme Regul; 1991; 31():3-12. PubMed ID: 1877392
[TBL] [Abstract][Full Text] [Related]
39. A conjugate of 5-fluorouridine-poly(L-lysine) and an antibody reactive with human colon carcinoma.
Hurwitz E; Stancovski I; Wilchek M; Shouval D; Takahashi H; Wands JR; Sela M
Bioconjug Chem; 1990; 1(4):285-90. PubMed ID: 2096921
[TBL] [Abstract][Full Text] [Related]
40. The GLP large scale preparation of immunotoxins containing deglycosylated ricin A chain and a hindered disulfide bond.
Ghetie V; Thorpe P; Ghetie MA; Knowles P; Uhr JW; Vitetta ES
J Immunol Methods; 1991 Sep; 142(2):223-30. PubMed ID: 1717600
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
